Parkinson's Insights

No Silver Bullet 4PD
"The Labs Don’t Lie: What Blood, Hair and Urine Reveal About PD" by Dr L Mischley preview

"The Labs Don’t Lie: What Blood, Hair and Urine Reveal About PD" by Dr L Mischley

In this session, Dr. Mischley joined us to explore the shift from traditional clinical observation to a data-driven, personalised paradigm for Parkinson’s management. Dr. Mischley argues that true progress requires building a new model—using objective biomarkers, patient-reported outcomes, and comprehensive laboratory testing—rather than simply relying on more traditional diagnostic frameworks. Key questions explored in this session include: The Data-Driven Approach: How we can move beyond surface-level symptoms to understand specific biomarkers in blood, hair and urine, that provide a deeper picture of health. Tracking Progression: Insights into the PRO-PD app and its role in tracking individual health journeys. Targeted Interventions: Understanding how diagnostic tools and laboratory findings help tailor management strategies, including the role of fatty acids, cholesterol, homocysteine, and Vitamin D in neurologic health. Predictive Metrics: An introduction to the RDW-to-Albumin Ratio (RAR) and how metrics like Heart Rate Variability (HRV) serve as tools for neurologic agility.

"Progress in Parkinson’s: from early signs to personalised intervention" with Prof A Noyce preview

"Progress in Parkinson’s: from early signs to personalised intervention" with Prof A Noyce

In this session, we explored the frontiers of Parkinson’s research, focusing on the critical questions shaping the future of care. We asked Professor Noyce how linking research profiles with national health records creates a more accurate "roadmap" for disease progression and whether we are now able to categorise Parkinson’s into specific sub-types for more personalised medicine. Key questions explored in this session include: The "Early Window": How can we act upon biological markers years before motor symptoms appear, and what role do lifestyle interventions like exercise and diet play in slowing the condition? Biological Staging: How close are we to a "Gold Standard" blood or skin test, and should we stop viewing Parkinson’s as a "motor disease" and start treating it as a systemic biological process? Technology & Innovation: How can we use consumer wearables to screen for early markers, and what biological pathways—such as inflammation or mitochondrial health—hold the most promise for a breakthrough? Global Reach: How is the PC3 project ensuring that new treatments are effective for diverse patient populations? Professor Noyce’s expert insights and his thoughts on the scientific milestones from the first half of 2026 that offer the most optimism.

The MIND Diet Masterclass:  Science-Backed Benefits for Brain Health and Parkinson's Symptoms

The MIND Diet Masterclass: Science-Backed Benefits for Brain Health and Parkinson's Symptoms

Event Description Join us for Food is Medicine for Parkinson's (Part 7): The MIND Diet Masterclass, where we explore the powerful connection between nutrition, brain protection, and physical mobility. In this session, we will break down the science of the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet, highlighting specific, evidence-based foods that help slow cognitive decline and support motor function. Whether you are living with Parkinson's, caring for a loved one, or looking to optimize your neurological health, you will walk away with practical, daily dietary strategies designed to protect your brain and keep you moving well. About the Speaker Dr. Puja Agarwal is a trained nutritionist and a nutritional epidemiologist at the RUSH Alzheimer’s Disease Center and an Assistant Professor of Internal Medicine at RUSH University Medical Center. She did her master’s in nutrition at the University of Delhi, India, PhD at University of Illinois, Chicago, and a post-doctoral fellowship at Rush. Her research focuses on the role of modifiable lifestyle factors in brain health, with a particular emphasis on nutrition and the MIND diet. She is widely recognized as an expert in the field, and her work has been well regarded for its contributions to understanding diet-related approaches to cognitive and motor health, parkinsonian signs and other age-related neurological conditions. Her past and current research work is funded by, Alzheimer’s Association, Michael J Fox Foundation for Parkinson’s Disease and the National Institutes of Health (NIH), specifically the National Institute on Aging (NIA).

How nutrition and simple kitchen strategies can transform symptom management for people living with Parkinson's

How nutrition and simple kitchen strategies can transform symptom management for people living with Parkinson's

In this webinar interview, co-authors Dr. Michael Okun and Emily Truscott discuss their upcoming book, The Parkinson's Plate: A Health and Diet Guide to Manage Your Journey. ​Moving away from dense science and restrictive rules, the authors share how they blended medical expertise with straightforward nutrition strategies tailored for real kitchens. The discussion covers essential topics such as gut health, medication interactions, and simple, high-calorie recipes designed to respect the daily energy and time of people living with Parkinson's and their caregivers. ​About the speakers: ​Dr Michael Okun is a leading global authority on Parkinson's and a bestselling author who serves as the Chair of Neurology at the University of Florida. He also acts as the National Medical Director for the Parkinson's Foundation, bringing decades of clinical insights and a deeply compassionate approach to improving daily quality of life. ​Emily Truscott is a clinical dietitian at the University of Florida who specialises in medical nutrition therapy for neurological conditions. Her work focuses on translating complex nutritional science into accessible, day to day practices, helping families create nourishing meals that support overall wellbeing without adding complexity to daily routines.

Michel Planquart

Michel Planquart

Diagnosed in 2020, Michel manages his condition with the dedicated rigour of an athlete. Through his holistic routine and practical tools, he empowers others to actively influence their own progression.

Newsletter

Subscribe to receive regular emails with the latest news, webinars, Bas Bloem podcasts, and Michael Okun posts.

Frequency
Prof. Bas Bloem

Prof. Bas Bloem

Radboud University

A world-leading neurologist and pioneer of patient-centred care, specialising in lifestyle and exercise interventions for Parkinson's.

EP 34 - Pesticides Callout!

EP 34 - Pesticides Callout!

🎙️ We’re back with Episode 34 of Parkinson Weekly, hosted by Prof. Bas Bloem.In Episode 34 of Parkinson Weekly, “Pesticides Callout!”, Prof. Bas Bloem delivers a powerful call to action regarding proposed changes to European pesticide regulations.Prof. Bloem explores concerns surrounding the current omnibus proposal, particularly the possibility that real-world evidence may no longer be considered when assessing the long-term safety of pesticides once they have been approved for market use. Drawing on decades of research into Parkinson’s disease and environmental risk factors, he explains why ongoing scrutiny of pesticides and other chemicals remains essential, especially as new evidence emerges from real-world exposure.The episode examines the limitations of current testing methods, the importance of post-approval monitoring, and recent research linking environmental exposures to an increased risk of neurodegenerative disease. Prof. Bloem also discusses the need to support greener agricultural alternatives and questions proposals that could extend the use of chemicals already identified as harmful to human health.This thought-provoking episode highlights the intersection of environmental policy, public health, and Parkinson’s disease, while urging policymakers to prioritise long-term population health when making regulatory decisions.Tune-in now to hear why Prof. Bloem believes real-world evidence must remain at the heart of efforts to protect future generations from potential environmental contributors to neurodegenerative disease.Have a question you’d like Bas to answer in a future episode? Email us at parkinsonweekly@gmail.com – we’d love to hear from you.

PodcastVideo
EP 33 - Four innovations to bridge the evidence-practice gap in Parkinson's disease allied health guidelines

EP 33 - Four innovations to bridge the evidence-practice gap in Parkinson's disease allied health guidelines

🎙️ We’re back with episode 33 of Parkinson Weekly, hosted by Prof. Bas Bloem.In Episode 33 of Parkinson Weekly, Prof. Bas Bloem discusses a newly published multidisciplinary allied health guideline for people living with Parkinson’s disease.Published in Parkinsonism and Related Disorders, the guideline introduces an innovative, problem-orientated approach to Parkinson’s care, moving beyond traditional single-discipline recommendations. Instead, it brings together input from physiotherapists, occupational therapists, speech-language therapists, dieticians, and other allied health professionals to address complex symptoms such as falls, fatigue, swallowing difficulties, constipation, breathing problems, and sexual health concerns.Bas highlights four key innovations: its multidisciplinary structure, decision support based on problems raised by people with Parkinson’s, full accessibility for patients themselves, and automated annual updates to ensure the guidance remains aligned with the latest evidence.This episode explores why this Dutch guideline may serve as a template for future Parkinson’s guidelines worldwide, supporting more collaborative, person-centred, and up-to-date care.A forward-looking episode on how multidisciplinary guidance could help shape the next era of Parkinson’s disease management.Read the full article here: https://pubmed.ncbi.nlm.nih.gov/42115018/Have a question you’d like Bas to answer in a future episode? Email us at parkinsonweekly@gmail.com – we’d love to hear from you.

PodcastVideo
Prof. Michael Okun

Prof. Michael Okun

University of Florida

A renowned neuroscientist and medical director of the Parkinson's Foundation, widely regarded as a global authority on advanced Parkinson's therapies.

How do you choose the best sleep sensor for Parkinson's disease and neurodegenerative disorders? Actigraphy refers to wearable sensors that estimate sleep, movement and potentially related measures. Manon Mijnsbergen and colleagues describe in a new paper in npj Parkinson's Disease how wearable movement sensors can objectively monitor sleep and nighttime movement in Parkinson's disease and what is needed to make these tools more accurate and useful in research and clinical care.
Key points:
- Wearable movement sensors can reliably detect differences in nighttime sleep and movement between folks w/ Parkinson's disease and healthy controls, making them valuable research and clinical tools.
- At least seven consecutive nights of monitoring, appropriate sensor placement and Parkinson's disease specific algorithms appear essential for obtaining reliable and meaningful data.
- Wrist-worn actigraphy performs well for estimating many sleep measures, however specialized sensor placement may be better for evaluating specific nighttime problems such as difficulty turning in bed or getting out of bed.
My take: This is a nice practical reviews on sleep monitoring in Parkinson's disease. We are moving beyond simply asking folks how they slept. Wearable technology now allows us to measure sleep in the home over multiple nights, capturing a more realistic picture of nighttime function. The next frontier is already evolving in combining movement sensors w/ heart rate, temperature and other biomarkers, along w/ Parkinson's disease specific algorithms, to create personalized sleep monitoring that truly guides care. Remember that total sleep time is really important and we tell folks in my clinic to shoot for ~6-8 hours if possible.
Here are 3 points that resonated w/ me:
1- Choose a wearable that has been validated in Parkinson's disease rather than assuming every consumer sleep tracker performs equally well.
2- Record sleep for at least seven nights because one night rarely reflects the true pattern of sleep in Parkinson's disease.
3- Match the sensor to the clinical question. A wrist sensor may be ideal for estimating sleep, while other sensor locations have special advantages.

How do you choose the best sleep sensor for Parkinson's disease and neurodegenerative disorders? Actigraphy refers to wearable sensors that estimate sleep, movement and potentially related measures. Manon Mijnsbergen and colleagues describe in a new paper in npj Parkinson's Disease how wearable movement sensors can objectively monitor sleep and nighttime movement in Parkinson's disease and what is needed to make these tools more accurate and useful in research and clinical care. Key points: - Wearable movement sensors can reliably detect differences in nighttime sleep and movement between folks w/ Parkinson's disease and healthy controls, making them valuable research and clinical tools. - At least seven consecutive nights of monitoring, appropriate sensor placement and Parkinson's disease specific algorithms appear essential for obtaining reliable and meaningful data. - Wrist-worn actigraphy performs well for estimating many sleep measures, however specialized sensor placement may be better for evaluating specific nighttime problems such as difficulty turning in bed or getting out of bed. My take: This is a nice practical reviews on sleep monitoring in Parkinson's disease. We are moving beyond simply asking folks how they slept. Wearable technology now allows us to measure sleep in the home over multiple nights, capturing a more realistic picture of nighttime function. The next frontier is already evolving in combining movement sensors w/ heart rate, temperature and other biomarkers, along w/ Parkinson's disease specific algorithms, to create personalized sleep monitoring that truly guides care. Remember that total sleep time is really important and we tell folks in my clinic to shoot for ~6-8 hours if possible. Here are 3 points that resonated w/ me: 1- Choose a wearable that has been validated in Parkinson's disease rather than assuming every consumer sleep tracker performs equally well. 2- Record sleep for at least seven nights because one night rarely reflects the true pattern of sleep in Parkinson's disease. 3- Match the sensor to the clinical question. A wrist sensor may be ideal for estimating sleep, while other sensor locations have special advantages.

PostOpen details

Recommended Activities